The Anti-EBV IgA ELISA is an enzyme linked immunosorbent assay intended for the quantitative detection of human IgA antibodies to the early antigen and nuclear antigen of the Epstein-Barr virus contained in human serum or plasma.

• Results are obtained in 2 hours.
• designed for differentiating nasopharyngeal carcinoma patients from normal population
• suit for mass screening.
• The specificity and sensitivity are both above 95%.

THE FEATURES 

• Use genetic engineered EBV-associated proteins as antigens.
• An ELISA test for detection of anti-(EBV EA+EBNA-1) IgA.
• With greater than 95% of specificity and sensitivity.
• Easy in assay procedure and result to interpretation.
• Quantitative determination or qualitative with Immune Status Ratio is available.
• Suitable for early screens diagnosis and prognosis of naspharynglal carcinoma.